The seven winners are individuals committed to the Foundation for the Development of Prevention and Better Care for Cardiovascular Disease in Women.
Presented by Marc Ladreit de Lacharrière, President of the Marc Ladreit de Lacharrière Foundation and Founding Partner of Agir pour le Cœur des Femmes, to Michel Valla, Mayor of Privas, a small town that mobilized its healthcare professionals to host two editions of the Bus du Cœur des Femmes and two Journées du Cœur des Femmes.
Co-Founders' Award Presented by Claire Mounier-Vehier and Thierry Drilhon to Thomas Fatôme, Director General of Assurance Maladie, for the exceptional operational contribution of the Assurance Maladie teams on the 70 stops of the Bus du Cœur des Femmes since 2021.
Ambassador Award Presented by Clotilde Halna du Fretay, Secretary General of the AXA Prévention Association, to Dr. Stephanie Clément, Ambassador for Agir pour le Cœur des Femmes in Pessac (33).
Scientific Award Presented by Charles Robinet-Duffo, CEO of the Henner Group, to Patrick Devos, biostatistician at Lille University Hospital, for his involvement in the National Observatory for Women's Health.
Women's Heart Day Award Presented by Emmanuelle Potin, General Delegate of the Clariane Foundation, to Carole Magnier and Claudie Vinchon, nurses, for Women's Heart Day in La Capelle (02).
Community Award Presented by Léna Cuoq, Project Manager at the Crédit Mutuel Alliance Fédérale Foundation, to Jean-Sébastien Vialatte, Mayor of Six-Fours-les-Plages.
Communication Award Presented by Catherine Barea, Director of Marketing Primevère and CSR, Lactalis Group, to Alain SIVAN, CEO of DDB Health Paris and TBWA\Adelphi agencies. Thank you and congratulations to all.
As part of this philanthropic partnership, a long-term action plan will be developed to engage employees, customers and the general public. Before this formal announcement, the Foundation presented a webinar on reopening after lockdown attended by several thousand Crédit Mutuel employees. [...]
As with many treatments, the prescription of statins, the most important drugs for reducing cardiovascular risk (CVR), is based on recommendations. These are rightly based on the estimation of the level of cardiovascular risk (CVR). However, there are several ways of assessing this CVR, and the [...]
This show gave me an opportunity to remind listeners that hospitalizations for heart attacks among women ages 45 to 54 are increasing 5% per year, mainly because of early exposure to smoking, stress, sedentary lifestyles, instability and combination contraceptives with estrogen. Traditional risk [...]